ACCUPRO

This brand name is authorized in Austria, Finland, Germany, Ireland, Lithuania, Poland, Romania, UK.

Active ingredients

The drug ACCUPRO contains one active pharmaceutical ingredient (API):

1	Quinapril UNII 33067B3N2M - QUINAPRIL HYDROCHLORIDE
	Quinapril is a potent angiotensin-converting enzyme (ACE) inhibitor. The mode of action of quinapril in humans and animals is to inhibit circulating and tissue ACE activity, thereby decreasing vasopressor activity and aldosterone secretion.
	Read more about Quinapril

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ACCUPRO Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09AA06	Quinapril	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	03738798, 03738829, 11856224
FI	Lääkealan turvallisuus- ja kehittämiskeskus	410316, 410738
GB	Medicines & Healthcare Products Regulatory Agency	14360, 14392, 14401, 14406
IE	Health Products Regulatory Authority	10077, 10251, 10278, 10294
LT	Valstybinė vaistų kontrolės tarnyba	1003701, 1003702, 1003703, 1004175, 1004176, 1004307, 1005359, 1016299
PL	Rejestru Produktów Leczniczych	100074870, 100074886, 100074892, 100125230, 100324716, 100324722, 100324739
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64840001, W64841001, W64842001